Leibniz-HKI and Analytik Jena develop facility for automated testing of drug candidates

A new robotics platform was inaugurated at the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI) on Thursday, June 15, 2023, in the presence of Thuringia's State Secretary for Research, Innovation and Economic Development. The highly modular facility serves the institute to accelerate the discovery of new antibiotics and is unique in Germany's academic sector in its combination of size, degree of automation and flexibility. The robotics platform was designed and built in close cooperation with Analytik Jena GmbH+Co. KG.

Leibniz-HKI and Analytik Jena develop facility for automated testing of drug candidates
At the inauguration of the robotics platform, Thuringian State Secretary Katja Böhler (center) cut the symbolic blue ribbon together with Leibniz-HKI Administrative Director Elke Jäcksch (right) and facility manager Luzia Gyr (left). Image Credit: Anna Schroll/Leibniz-HKI

The antibiotics crisis is one of the greatest medical challenges of our time. Increasing resistance means that people are once again dying from bacterial infections that were long considered to be easily treatable.

At the same time, the pharmaceutical industry has largely withdrawn from the less profitable development of new antibiotics. A major reason for this is lack of profitability: antibiotics are used sparingly, sold at low prices, and also have short treatment durations.

Publicly funded research is trying to close this gap. "As a state, we provide targeted support for application-oriented research in order to take the results all the way to value creation in Thuringia," said Katja Böhler, State Secretary for Research, Innovation and Economic Development at the Thuringian Ministry of Economic Affairs, Science and Digital Society. She referred in particular to the innovation umbrella program "Thuringia MOTIVation," which bundles all related funding instruments. "Future-oriented cooperation between science and industry makes Jena and Thuringia a high-tech location with many highly qualified jobs. The new robotics facility is an example of how well this interplay between public and private players works here in the state."

"Antibiotic development with the help of public research funding is a major challenge that our institute is taking on," says Pierre Stallforth, deputy director and project leader of the new robotics platform at Leibniz-HKI. This was achieved most recently with the tuberculosis agent BTZ-043, which was discovered at Leibniz-HKI and further developed in cooperation with academic partners and industry.

In the future, the new robotics platform set up at the HKI Biotech Center should be able to perform experiments faster and more accurately, as repetitive steps are always carried out in exactly the same way. "The combination of automation, data analysis and innovative research approaches increases the chances of success in identifying new antibiotics," explains Luzia Gyr, head of the facility.

The technology platform was designed in close development cooperation with Analytik Jena. The most important requirement of the future users was that the system should be as flexible as possible.

Industrial plants are normally characterized by a fixed process sequence. Here we have a platform that is equipped for the future and can respond to the high variability of the research topics of the institute and its partners."

Matthias Fischer, Team Leader of Automation, Analytik Jena.

The project was technically very demanding, but due to the short distances and the very intensive coordination of all participants directly on site, it could be realized in a relatively short time."

Lars Böttcher, Vice President of Technology, Analytik Jena.

The construction of the modern facility was only made possible by extensive public funding. It was largely funded by the German Federal Ministry of Education and Research as part of the Zwanzig20 consortium InfectControl and its follow-up projects. Additional funding was provided by the German Research Foundation as part of the Balance of the Microverse cluster of excellence and by the state of Thuringia with money from the European Regional Development Fund (ERDF). The total volume of the investment is three million euros. In addition, the Free State of Thuringia is funding the RoboThür research group, which has applied jointly with the Friedrich Schiller University of Jena, with one million euros, thus enabling the recruitment of highly qualified personnel for the platform.

The new robotics platform will not only be available to the Leibniz-HKI research groups, but also to the University of Jena and other research institutions and industrial partners with which the institute cooperates. The commissioning of the system, which has just taken place, will now be followed by a phase of setting up the first test series and validating the results, which will take several months.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Analytik Jena AG. (2024, March 12). Leibniz-HKI and Analytik Jena develop facility for automated testing of drug candidates. News-Medical. Retrieved on April 17, 2024 from https://www.news-medical.net/news/20230623/Leibniz-HKI-and-Analytik-Jena-develop-facility-for-automated-testing-of-drug-candidates.aspx.

  • MLA

    Analytik Jena AG. "Leibniz-HKI and Analytik Jena develop facility for automated testing of drug candidates". News-Medical. 17 April 2024. <https://www.news-medical.net/news/20230623/Leibniz-HKI-and-Analytik-Jena-develop-facility-for-automated-testing-of-drug-candidates.aspx>.

  • Chicago

    Analytik Jena AG. "Leibniz-HKI and Analytik Jena develop facility for automated testing of drug candidates". News-Medical. https://www.news-medical.net/news/20230623/Leibniz-HKI-and-Analytik-Jena-develop-facility-for-automated-testing-of-drug-candidates.aspx. (accessed April 17, 2024).

  • Harvard

    Analytik Jena AG. 2024. Leibniz-HKI and Analytik Jena develop facility for automated testing of drug candidates. News-Medical, viewed 17 April 2024, https://www.news-medical.net/news/20230623/Leibniz-HKI-and-Analytik-Jena-develop-facility-for-automated-testing-of-drug-candidates.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.